Position in ROIV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$25,535,724
+$9,987,521 QoQ
Shares Held
721,552
+28.5% QoQ
Ownership
0.100%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#76
of 494 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 68%
Shared 0%
None 32%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Legal & General Group Plc holds $3,286,710,193 across 292 Biotechnology names. ROIV ranks #16 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,870,015 | $928,892,550 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
759,971 | $473,872,316 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
924,561 | $278,320,596 | |
| 4 | RPRX |
Royalty Pharma plc
|
3,800,504 | $213,094,258 | |
| 5 | INCY |
Incyte Corp
|
1,605,980 | $182,053,892 | |
| 6 | ARGX |
Argenx SE
|
177,164 | $164,367,443 | |
| 7 | INSM |
INSMED Inc
|
826,431 | $88,114,072 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
381,366 | $71,422,223 |
All Filings in ROIV
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,535,724 | 721,552 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $15,548,203 | 561,307 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $12,795,902 | 589,673 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $8,311,346 | 549,329 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $6,887,726 | 611,156 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $6,199,597 | 614,430 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $7,131,808 | 602,858 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $6,988,484 | 605,588 | Shares | Defined | 2025-02-28 | |
| 2024-06-30 | $5,636,873 | 533,290 | Shares | Defined | 2025-05-29 | |
| 2024-03-31 | $4,577,943 | 434,340 | Shares | Defined | 2025-05-29 | |
| 2023-12-31 | $3,301,226 | 293,965 | Shares | Defined | 2025-05-29 | |
| 2023-09-30 | $3,447,035 | 295,123 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $3,297,006 | 327,084 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $864,072 | 117,083 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $810,944 | 101,495 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $315,292 | 97,917 | Shares | Defined | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||